Table 2.
Variable | No. of patients | No. of events | HR | 95% CI | P value |
---|---|---|---|---|---|
Age | - | - | 1.06 | 1.02–1.11 | 0.003 |
Sex | |||||
Male | 18 | 14 | 3.95 | 1.76–8.84 | < 0.001 |
Female | 38 | 20 | Reference | ||
Positive lymph nodes | |||||
Yes | 7 | 6 | 4.45 | 1.67–11.87 | 0.003 |
No | 49 | 28 | Reference | ||
Arterial enhancement pattern | |||||
Hypovascular | 10 | 7 | 5.33 | 1.52–19.90 | 0.009 |
Peripherally enhancing | 29 | 20 | 1.65 | 0.67–4.09 | 0.280 |
Hypervascular | 17 | 7 | Reference |
Abbreviations: ICC, intrahepatic cholangiocarcinoma; HR, hazard ratio.
A Cox proportional hazards model analysis initially included age (continuous variable), sex, prehepatectomy CA19–9 level (> 37 vs ≤ 37 ng/mL), prehepatectomy chemotherapy, lymph node metastasis, number of ICC (multiple vs single), largest ICC diameter (> 3 vs ≤ 3 cm), and arterial enhancement patter. A backward elimination with a threshold P value of 0.20 was used to select variables for the final models.